Kidney stones are one of the most common urological diseases worldwide and represent a growing burden on healthcare systems. Traditional diagnostic procedures and therapeutic approaches, from imaging and drug-based stone dissolution to invasive surgical methods, are fraught with limitations. Nanomedicine opens up new perspectives here: Nanomaterials enable more precise early detection, improve imaging, have antioxidant and antibacterial effects, transport drugs in a more targeted manner and can even control biofilm-associated infections. The following article presents the latest advances in this field and discusses the clinical relevance for nephrologists.
You May Also Like
- "Survey of Health, Ageing and Retirement in Europe" (SHARE)
Analysis of polypharmacy in ≥65-year-olds
- New perspectives for clinics and research
Ageing, cellular senescence and Parkinson’s disease
- From early intervention to individualization
The new guidelines at a glance
- Artificial intelligence
Dr. ChatGPT: Large language models in everyday clinical practice
- Focus on prevention
Colorectal cancer screening – an update
- COPD therapy
Drug therapy – Update 2025
- From symptom to diagnosis
Oncology – Thymoma
- Shared decision making